Journal of Orthopedics and Joint Surgery

Register      Login

VOLUME 4 , ISSUE 2 ( July-December, 2022 ) > List of Articles

Original Article

Musculoskeletal Symptoms during COVID-19 Pandemic in a Tertiary Care Hospital in South India

Vetrivel Chezian Sengodan, Marimuthu Sivagnanam, Ranjithkumar Selvaraj

Keywords : COVID-19, Knee pain, Musculoskeletal symptoms, Myalgia

Citation Information : Sengodan VC, Sivagnanam M, Selvaraj R. Musculoskeletal Symptoms during COVID-19 Pandemic in a Tertiary Care Hospital in South India. 2022; 4 (2):70-73.

DOI: 10.5005/jp-journals-10079-1099

License: CC BY-NC 4.0

Published Online: 31-05-2022

Copyright Statement:  Copyright © 2022; The Author(s).


Background: The symptoms of COVID-19 include fever, myalgia, arthralgia, fatigue, headache, sore throat, dry cough, anosmia, ageusia/dysgeusia, and progression to viral pneumonia. Musculoskeletal symptoms such as fatigue, myalgia, and arthralgia are common COVID-19 symptoms, but their prevalence has not yet been systematically investigated. Hence, our study aims to know the incidence of musculoskeletal symptoms in COVID-19 infection and their relationship between comorbidities like diabetes and hypertension. Methods: In our study, 1053 COVID-19 infected patients confirmed by the RT-PCR method were included. For all the patients in our study, detailed history of musculoskeletal symptoms and comorbidities were collected. Basic investigations were done for all the patients and appropriate treatment was given. The patients were followed up for persistence of musculoskeletal symptoms after discharge from the hospital. Results: During COVID-19 infection, knee joint pain was present among 251 patients (23.8%), generalized myalgia in 147 patients (14%) and 40 patients (3.8%) had both knee joint pain and generalized myalgia. In these patients, during the post-COVID follow-up, 198 patients had persistent knee joint pain, 100 patients had persistence of generalized myalgia and 38 patients had persistence of both knee pain and myalgia, whereas 19 patients developed knee joint pain and one patient developed generalized myalgia after COVID-19 infection. From our study, it is evident that the musculoskeletal symptoms are more during COVID-19 infection than during the pre-COVID period. Compared with pre-COVID status, generalized myalgia is more during the post-COVID follow-up period. This was analyzed with Cochran's Q test and was found to be statistically significant (p < 0.05). Conclusion: Our study showed an increased incidence of musculoskeletal symptoms during and after COVID-19 infection, the most common being generalized myalgia followed by knee joint pain. In patients with comorbidities like diabetes and hypertension, it is evident that musculoskeletal symptoms like knee joint pain and generalized myalgia are increased during COVID-19 infection.

  1. Lian J, Jin X, Hao S, et al. Analysis of epidemiological and clinical features in older patients with coronavirus disease 2019 (COVID-19) outside Wuhan. Clin Infect Dis 2020;71(15):740–747. DOI: 10.1093/cid/ciaa242
  2. Lotfi M, Hamblin MR, Rezaei N. COVID-19: transmission, prevention, and potential therapeutic opportunities. Clin Chim Acta 2020;508:254–266. DOI: 10.1016/j.cca.2020.05.044
  3. Cipollaro L, Giordano L, Padulo J, et al. Musculoskeletal symptoms in SARS-CoV-2 (COVID-19) patients. J Orthop Surg Res 2020;15(1):178. DOI: 10.1186/s13018-020-01702-w
  4. Li X, Xu S, Yu M, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol 2020;146(1):110–118. DOI: 10.1016/j.jaci.2020.04.006
  5. Mullol J, Alobid I, Mariño-Sánchez F, et al. The loss of smell and taste in the covid-19 outbreak: a tale of many countries. Curr Allergy Asthma Rep 2020;20(10):61. DOI: 10.1007/s11882-020-00961-1
  6. Ramani SL, Samet J, Franz CK, et al. Musculoskeletal involvement of COVID-19: review of imaging. Skeletal Radiol 2021;50(9):1763–1773. DOI: 10.1007/s00256-021-03734-7
  7. Revzin MV, Raza S, Srivastava NC, et al. Multisystem imaging manifestations of COVID-19, part 2: from cardiac complications to pediatric manifestations. Radiographics 2020;40(7):1866–92. DOI: 10.1148/rg.2020200195
  8. Martinez-Urbistondo M, Mora-Vargas A, Expósito-Palomo E, et al. Inflammatory-related clinical and metabolic outcomes in covid-19 patients. Mediators Inflamm 2020;2020:2914275. DOI: 10.1155/2020/2914275. eCollection 2020
  9. Guan W, Ni Z, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020;382:1708–1720 DOI: 10.1056/NEJMoa2002032
  10. Lechien JR, Chiesa-Estomba CM, De Siati DR, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol 2020;277(8):2251–2261. DOI: 10.1007/s00405-020-05965-1
  11. Liang WH, Guan WJ, Li CC, et al. Clinical characteristics and outcomes of hospitalised patients with COVID-19 treated in Hubei (epicenter) and outside Hubei (non-epicenter): a nationwide analysis of China. Eur Respir J 2020;55(6):2000562. DOI: 10.1183/13993003.00562-2020
  12. Goyal P, Choi JJ, Pinheiro LC, et al. Clinical characteristics of Covid-19 in New York city. N Engl J Med 2020;382(24):2372–2374. DOI: 10.1056/NEJMc2010419
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.